Compare Stocks

→ A new way to collect income from stocks (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BON Bon Natural Life	$4.24 +19.2%	$4.51	$3.47 ▼ $13.88	$4.96M	-1.08	11,937 shs	120,346 shs
MDWD MediWound	$17.44 -4.6%	$14.84	$7.10 ▼ $18.75	$165.51M	0.93	69,689 shs	156,507 shs
MTEX Mannatech	$8.35 -1.8%	$8.68	$7.50 ▼ $15.93	$15.69M	1.2	1,218 shs	190 shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BON Bon Natural Life	-0.69%	-14.29%	-21.74%	-30.69%	-73.13%
MDWD MediWound	+14.25%	+14.90%	+14.25%	+41.16%	+44.51%
MTEX Mannatech	0.00%	+0.71%	-5.66%	+4.81%	-42.95%

A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BON Bon Natural Life	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MDWD MediWound	1.148 of 5 stars	3.5	3.0	0.0	0.0	0.0	0.8	0.6
MTEX Mannatech	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BON Bon Natural Life	N/A	N/A	N/A	N/A
MDWD MediWound	3.00	Buy	$32.00	83.49% Upside
MTEX Mannatech	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest MDWD, MTEX, and BON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/22/2024	MDWD MediWound	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$28.00

(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BON Bon Natural Life	$29.52M	0.17	$5.89 per share	0.72	$30.65 per share	0.14
MDWD MediWound	$18.69M	8.86	N/A	N/A	$3.43 per share	5.08
MTEX Mannatech	$131.96M	0.12	N/A	N/A	$5.64 per share	1.48

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BON Bon Natural Life	$4.60M	N/A	0.00	∞	N/A	N/A	N/A	N/A	5/10/2024 (Estimated)
MDWD MediWound	-$6.72M	-$0.77	N/A	N/A	N/A	-35.94%	-20.22%	-10.08%	6/4/2024 (Estimated)
MTEX Mannatech	-$2.24M	-$1.20	N/A	∞	N/A	-1.70%	-19.19%	-4.99%	5/10/2024 (Estimated)

Latest MDWD, MTEX, and BON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/21/2024	Q4 2023	MDWD MediWound	-$0.23	-$0.19	+$0.04	-$0.19	$5.33 million	$5.34 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BON Bon Natural Life	N/A	N/A	N/A	N/A	N/A
MDWD MediWound	N/A	N/A	N/A	N/A	N/A
MTEX Mannatech	$0.20	2.40%	+1.72%	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BON Bon Natural Life	0.03	2.52	2.41
MDWD MediWound	N/A	4.59	4.33
MTEX Mannatech	0.09	1.07	0.51

Ownership

Institutional Ownership

Company	Institutional Ownership
BON Bon Natural Life	0.57%
MDWD MediWound	46.83%
MTEX Mannatech	12.98%

Insider Ownership

Company	Insider Ownership
BON Bon Natural Life	26.48%
MDWD MediWound	9.20%
MTEX Mannatech	53.10%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BON Bon Natural Life	96	1.17 million	863,000	Not Optionable
MDWD MediWound	100	9.49 million	8.62 million	Optionable
MTEX Mannatech	228	1.88 million	884,000	Not Optionable

MDWD, MTEX, and BON Headlines

Source	Headline
	Mannatech (NASDAQ:MTEX) Receives New Coverage from Analysts at StockNews.com americanbankingnews.com - April 16 at 2:22 AM
	Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com americanbankingnews.com - April 8 at 2:26 AM
	MTEX Stock Earnings: Mannatech Reported Results for Q4 2023 investorplace.com - March 28 at 2:01 PM
	Mannatech Posts Narrower Loss In Q4; Net Sales Down 4.7% markets.businessinsider.com - March 28 at 7:47 AM
	Mannatech Reports Financial Results for Fourth Quarter and Full Year 2023 businesswire.com - March 28 at 7:02 AM
	Mannatech Reports Financial Results for Fourth Quarter and Full Year 2023 businesswire.com - March 28 at 7:00 AM
	Mannatech Names Landen Fredrick as Next CEO marketwatch.com - March 15 at 12:24 AM
	Mannatech Announces Retirement of Alfredo Bala and Promotion of Landen Fredrick to President and CEO finance.yahoo.com - March 14 at 12:35 AM
	MILAN Village, MTEX 2024 steal the spotlight with cultural riches and cutting-edge technology in Visakhapatnam msn.com - February 22 at 9:54 AM
	Empowered Kiwis Teams Up With Mannatech In New Zealand scoop.co.nz - January 17 at 1:56 AM
	This is what Albuquerque's Economic Development Department is focused on in 2024 bizjournals.com - January 3 at 8:30 PM
	Mannatech Inc MNNN morningstar.com - January 3 at 3:29 PM
	Delta elevates MTEX printers with increased automation msn.com - January 3 at 3:29 PM
	Mannatech Inc MTEX morningstar.com - November 8 at 9:43 AM
	Mannatech GAAP EPS of $0.01, revenue of $32.6M, continues to skip dividend payment msn.com - November 7 at 8:12 AM
	Mannatech Inc. Reports Retreat In Q3 Bottom Line markets.businessinsider.com - November 7 at 8:12 AM
	Mannatech Reports Third Quarter End 2023 Financial Results finance.yahoo.com - November 7 at 8:12 AM
	Mannatech Inc (MTEX) Reports Decrease in Third Quarter Net Sales and Net Income for 2023 finance.yahoo.com - November 7 at 8:12 AM
	Australia-Based Star Scientific Chooses New Mexico For North America Expansion losalamosreporter.com - October 26 at 12:25 AM
	German antenna manufacturer to set up shop in Albuquerque bizjournals.com - October 7 at 4:14 PM
	MTEX - Mannatech, Incorporated uk.finance.yahoo.com - August 20 at 11:48 PM
	Mannatech Reports Second Quarter End 2023 Financial Results finance.yahoo.com - August 14 at 8:26 PM
	A Look At The Fair Value Of Mannatech, Incorporated (NASDAQ:MTEX) finance.yahoo.com - July 14 at 1:35 PM
	Landen Fredrick Elevated to President and Chief Operating Officer at Mannatech markets.buffalonews.com - June 15 at 6:15 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bon Natural Life

NYSE:BON

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

MediWound

NASDAQ:MDWD

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Mannatech

NASDAQ:MTEX

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial